Table I.
Summary of Performance in CAPRI Rounds 13–19
| Target | Receptor–ligand | Typea | I_RMSD (Å)b | L_RMSD (Å)b | F_natb | #h/m/a/ic |
|---|---|---|---|---|---|---|
| T29 | Trm8/Trm8 tRNA guanine-N(7) methyltransferase | B–U | 9.2 (8) | 26.5 (4) | 0.04 (8) | 0/0/0/10 |
| T30 | Rnd1/Rho GTPase binding domain (RBD) | U–U | 45.7 (3) | 16.7 (3) | 0.00 | 0/0/0/10 |
| T33 | RNA/protein | H–H | 21.0 (1) | 14.2 (1) | 0.09 (8) | 0/0/0/10 |
| T34 | RNA/protein | B–H | 1.5 (1) | 1.7 (1) | 0.49 (3) | 0/4/2/4 |
| T37 | Arf6/LZ2 | U–H | 9.8 (1) | 26.8 (4) | 0.00 | 0/0/0/10 |
| T38 | Centaurin/FHA | U–H | 4.6 (1) | 18.7 (10) | 0.20 (10) | 0/0/0/10 |
| T39 | Centaurin/FHA | U–B | 10.2 (3) | 18.4 (3) | 0.08 (5) | 0/0/0/10 |
| T40 | Trypsin/inhibitor | U–B | 0.5 (1) | 1.4 (1) | 0.81 (1) | 3/0/0/0 |
The rank of the model in our submission is shown in parentheses.
a
Starting structures: B, bound; U, unbound; H, homology unbound.
b
Measures according to CAPRI assessors (http://capri.ebi.ac.uk). I_rmsd, interface backbone rmsd; L_rmsd, ligand backbone rmsd; F_nat, fraction of native contacts.
c
Counts of models according to accuracy: h, high; m, medium; a, acceptable; i, incorrect.